Literature DB >> 7018384

Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.

N K Fujita, J E Edwards.   

Abstract

The combination of amphotericin B and rifampin was synergistic in vitro in both inhibiting and killing seven strains of Cryptococcus neoformans by the checkerboard microtitration technique.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7018384      PMCID： PMC181383          DOI： 10.1128/AAC.19.1.196

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Synergism of amphotericin B and 5-fluorocytosine for candida species.

Authors:  J Z Montgomerie; J E Edwards; L B Guze
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.

Authors:  J P Utz; I L Garriques; M A Sande; J F Warner; G L Mandell; R F McGehee; R J Duma; S Shadomy
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

3.  Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis.

Authors:  J E Sippel; I A Mikhail; N I Girgis; H H Youssef
Journal:  Am Rev Respir Dis       Date:  1974-05

4.  Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Authors:  L Verbist; A Gyselen
Journal:  Am Rev Respir Dis       Date:  1968-12

5.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Synergistic action of amphotericin B and rifampin against Candida species.

Authors:  W H Beggs; G A Sarosi; M I Walker
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

7.  In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin.

Authors:  D Rifkind; E D Crowder; R N Hyland
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.

Authors:  G S Kobbayashi; G Medoff; D Schlessinger; C N Kwan; W E Musser
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

9.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.

Authors:  H J Harwick; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191
View more
  9 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 3.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

4.  Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B.

Authors:  C J Clancy; Y C Yu; A Lewin; M H Nguyen
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 5.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

6.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 7.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Synergistic action of amphotericin B and rifampin against Rhizopus species.

Authors:  J C Christenson; I Shalit; D F Welch; A Guruswamy; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

9.  Novel synergism of two antifungal agents, copiamycin and imidazole.

Authors:  J Uno; M L Shigematsu; T Arai
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.